Clinical Trial Update: Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study evaluating AS1409 in patients with metastatic renal cell carcinoma or metastatic malignant melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• AS1409

Snippet

Sponsor: Antisoma Research | Conditions: Metastatic Renal Cell Carcinoma, Metastatic Malignant Melanoma | Phase 1 | Status: COMPLETED